Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.11 is 16% below its 5-year average of 1.32, around the middle of its 5-year range (0.13–2.75).
As of the fiscal period ended Tuesday, June 30, 2026. 39.06% below its 12-month average of 1.82.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.11.
QUICK RATIO (ACID-TEST)
1.11
QUICK RATIO (ACID-TEST) AVG TTM
1.82
QUICK RATIO (ACID-TEST) AVG 3Y
1.48
QUICK RATIO (ACID-TEST) AVG 5Y
1.32
QUICK RATIO (ACID-TEST) AVG 10Y
1.14
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-39.06%
CURRENT VS 3Y AVG
-25.08%
CURRENT VS 5Y AVG
-15.68%
CURRENT VS 10Y AVG
-2.20%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-66.86%
vs the sector median at left
Allarity Therapeutics, Inc.
Market Cap
$15.65M
Quick Ratio (Acid-Test)
1.11
TTM Avg
1.82
3Y Avg
1.48
5Y Avg
1.32
Market Cap
$15.35M
Quick Ratio (Acid-Test)
0.76
TTM Avg
1.36
3Y Avg
2.82
5Y Avg
3.25
Market Cap
$15.78M
Quick Ratio (Acid-Test)
2.09
TTM Avg
1.13
3Y Avg
1.21
5Y Avg
2.30
Market Cap
$15.24M
Quick Ratio (Acid-Test)
1.24
TTM Avg
4.22
3Y Avg
12.60
5Y Avg
18.98
Market Cap
$15.10M
Quick Ratio (Acid-Test)
1.64
TTM Avg
1.86
3Y Avg
2.17
5Y Avg
1.89
Market Cap
$15.03M
Quick Ratio (Acid-Test)
26.25
TTM Avg
8.96
3Y Avg
10.61
5Y Avg
33.19
Market Cap
$16.50M
Quick Ratio (Acid-Test)
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
Market Cap
$16.53M
Quick Ratio (Acid-Test)
3.37
TTM Avg
8.28
3Y Avg
7.56
5Y Avg
6.68
Market Cap
$16.84M
Quick Ratio (Acid-Test)
6.03
TTM Avg
7.38
3Y Avg
5.70
5Y Avg
5.02
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | $15.65M | 1.11 | 1.82 | 1.48 | 1.32 |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.35M | 0.76 | 1.36 | 2.82 | 3.25 |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 2.09 | 1.13 | 1.21 | 2.30 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.24M | 1.24 | 4.22 | 12.60 | 18.98 |
| Jin Medical International Ltd. (ZJYL)vs › | $15.10M | 1.64 | 1.86 | 2.17 | 1.89 |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.03M | 26.25 | 8.96 | 10.61 | 33.19 |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | 1.65 | 3.34 | 3.94 | 7.05 |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.53M | 3.37 | 8.28 | 7.56 | 6.68 |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | 6.03 | 7.38 | 5.70 | 5.02 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.81M | 1.96 | 1.25 | 1.80 | 4.00 |
Quick Ratio
1.11
Excludes inventory
Current Ratio
1.11
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.11 |
| 2026-03-31 | 1.23 |
| 2025-12-31 | 2.13 |
| 2025-09-30 | 2.33 |
| 2025-06-30 | 2.31 |
| 2025-03-31 | 2.66 |
| 2024-12-31 | 2.06 |
| 2024-09-30 | 2.75 |
| 2024-06-30 | 2.01 |
| 2024-03-31 | 0.13 |
| 2023-12-31 | 0.14 |
| 2023-09-30 | 0.23 |
| 2023-06-30 | 0.19 |
| 2023-03-31 | 0.26 |
| 2022-12-31 | 0.44 |
| 2022-09-30 | 0.47 |
| 2022-06-30 | 0.88 |
| 2022-03-31 | 1.35 |
| 2021-12-31 | 1.03 |
| 2021-09-30 | 1.99 |
| 2021-06-30 | 1.96 |
| 2021-03-31 | 0.35 |
| 2020-12-31 | 0.31 |
| 2020-09-30 | 0.47 |
| 2020-06-30 | 0.52 |
| 2020-03-31 | 0.40 |
| 2019-12-31 | 0.71 |
| 2019-09-30 | 0.29 |
| 2019-06-30 | 0.49 |
| 2019-03-31 | 0.28 |
| 2018-12-31 | 0.41 |
| 2018-09-30 | 0.77 |
| 2018-06-30 | 0.00 |
| 2018-03-31 | 1.55 |
| 2017-12-31 | 0.67 |
| 2017-09-30 | 3.90 |
| 2017-06-30 | 5.53 |
| 2017-03-31 | 5.02 |
| 2016-12-31 | 3.24 |
| 2016-09-30 | 5.48 |
| 2016-06-30 | 48.05 |
| 2016-03-31 | 5.78 |
| 2015-12-31 | 5.68 |
| 2015-09-30 | 9.92 |
| 2015-06-30 | 11.60 |
| 2015-03-31 | 100.50 |